Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost,
morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis …

Diabetic cardiomyopathy (DCM) is a cardiac dysfunction which affects approximately 12% of
diabetic patients, leading to overt heart failure and death. However, there is not an efficient …

Aims Insulin like growth factor binding protein 7 (IGFBP7) is a marker of senescence
secretome and a novel biomarker in patients with heart failure (HF). We evaluated the …

Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

This state-of-the-art review aims to provide an up-to-date look at breakthrough omic
technologies that are helping to unravel heart failure (HF) disease mechanisms and …

The relationship between diabetes and heart failure is complex and bidirectional.
Nevertheless, the existence of a cardiomyopathy attributable exclusively to diabetes has …

Diabetic cardiomyopathy (DCM) is commonly defined as cardiomyopathy in patients with
diabetes mellitus in the absence of coronary artery disease and hypertension. As DCM is …

Heart failure (HF) is a rising global cardiovascular epidemic driven by aging and chronic
inflammation. As elderly populations continue to increase, precision treatments for age …

Background: Increased activity of IGFBP7 (insulin-like growth factor–binding protein-7) is
associated with cellular senescence, tissue aging, and obesity. IGFBP7 may be related to …